Achyut Healthcare Ltd vs Novartis India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Achyut Healthcare Ltd is ₹ 5.37 as of 06 May 15:30 . The P/E Ratio of Achyut Healthcare Ltd changed from 342.5 on March 2022 to 163 on March 2025 . This represents a CAGR of -16.94% over 4 yearsThe P/E Ratio of Novartis India Ltd changed from 65.2 on March 2021 to 19.2 on March 2025 . This represents a CAGR of -21.69% over 5 years The Market Cap of Achyut Healthcare Ltd changed from ₹ 13.85 crore on March 2022 to ₹ 76.79 crore on March 2025 . This represents a CAGR of 53.45% over 4 yearsThe Market Cap of Novartis India Ltd changed from ₹ 1362 crore on March 2021 to ₹ 1938 crore on March 2025 . This represents a CAGR of 7.30% over 5 years The revenue of Achyut Healthcare Ltd for the Dec '25 is ₹ 1.61 crore as compare to the Sep '25 revenue of ₹ 2.66 crore. This represent the decline of -39.47% The revenue of Novartis India Ltd for the Dec '25 is ₹ 94.65 crore as compare to the Sep '25 revenue of ₹ 99.73 crore. This represent the decline of -5.09% The ebitda of Achyut Healthcare Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.19 crore. This represent the decline of -78.95% The ebitda of Novartis India Ltd for the Dec '25 is ₹ 31.11 crore as compare to the Sep '25 ebitda of ₹ 33.28 crore. This represent the decline of -6.52% The net profit of Achyut Healthcare Ltd changed from ₹ 0.03 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The net profit of Novartis India Ltd changed from ₹ 25.74 crore to ₹ 16.09 crore over 7 quarters. This represents a CAGR of -23.55% The Dividend Payout of Achyut Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novartis India Ltd changed from 118.09 % on March 2021 to 61.15 % on March 2025 . This represents a CAGR of -12.33% over 5 years .

About Achyut Healthcare Ltd

Achyut Healthcare Limited was incorporated as Achyut Securities Private Limited' on January 11, 1996 as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company name was changed to Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002.
Subsequently, the Company got converted from a Private Limited to Public Limited and the name of the Company changed to Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021 was issued to the Company by Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

FAQs for the comparison of Achyut Healthcare Ltd and Novartis India Ltd

Which company has a larger market capitalization, Achyut Healthcare Ltd or Novartis India Ltd?

Market cap of Achyut Healthcare Ltd is 126 Cr while Market cap of Novartis India Ltd is 2,594 Cr

What are the key factors driving the stock performance of Achyut Healthcare Ltd and Novartis India Ltd?

The stock performance of Achyut Healthcare Ltd and Novartis India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Achyut Healthcare Ltd and Novartis India Ltd?

As of May 6, 2026, the Achyut Healthcare Ltd stock price is INR ₹5.37. On the other hand, Novartis India Ltd stock price is INR ₹1050.7.

How do dividend payouts of Achyut Healthcare Ltd and Novartis India Ltd compare?

To compare the dividend payouts of Achyut Healthcare Ltd and Novartis India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.